Bioshares Biotechnology Products Fund ETF Forecast

Buy or Hold candidate since Jun 18, 2026 Gain 3.06%

The BioShares Biotechnology Products Fund ETF price gained 1.53% on the last trading day (Tuesday, 23rd Jun 2026), rising from $91.16 to $92.55. During the last trading day the ETF fluctuated 0.146% from a day low at $92.55 to a day high of $92.69. The price has risen in 7 of the last 10 days and is up by 10.1% over the past 2 weeks. Volume fell on the last day by -7 thousand shares and in total, 3 thousand shares were bought and sold for approximately $305.32 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The ETF lies in the upper part of a wide and weak rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $93.39 will firstly indicate a stronger rate of rising. Given the current short-term trend, the ETF is expected to rise 6.62% during the next 3 months and, with a 90% probability hold a price between $90.49 and $99.57 at the end of this 3-month period.

BBP Signals & Forecast

The BioShares Biotechnology Products Fund ETF holds buy signals from both short and long-term Moving Averages giving a positive forecast for the ETF. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $89.60 and $87.06. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday, June 02, 2026, and so far it has risen 10.76%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.

Support, Risk & Stop-loss for BioShares Biotechnology Products Fund ETF

BioShares Biotechnology Products Fund finds support from accumulated volume at $90.39 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the ETF tends to have controlled movements and therefore the general risk is considered low. However, be aware of low or falling volume and make sure to keep an eye on the ETF. During the last day, the ETF moved $0.135 between high and low, or 0.146%. For the last week the ETF has had daily average volatility of 1.38%.

The BioShares Biotechnology Products Fund ETF is overbought on RSI14 and lies in the upper part of the trend. Normally this may pose a good selling opportunity for the short-term trader, but some ETFS may go long and hard while being overbought and the RSI is still moving upwards. Regardless, the high RSI together with the trend position increases the risk and higher daily movements (volatility) should be expected. A correction down in the nearby future seems very likely, and it is of great importance that the ETF manages to break the trend before that occurs.

Our recommended stop-loss: $89.15 (-3.67%) (This ETF has low daily movements and this gives low risk. The RSI14 is 77 and this increases the risk substantially. There is a buy signal from a pivot bottom found 14 days ago.)

Trading Expectations (BBP) For The Upcoming Trading Day Of Wednesday 24th

For the upcoming trading day on Wednesday, 24th we expect BioShares Biotechnology Products Fund to open at $92.60, and during the day (based on 14 day Average True Range), to move between $91.78 and $93.32, which gives a possible trading interval of +/-$1.55 (+/-1.69%) up or down from last closing price. If BioShares Biotechnology Products Fund takes out the full calculated possible swing range there will be an estimated 1.69% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $90.39, some $2.16 (2.33%) from the current price of $92.55, our system finds the risk reward attractive.

Is BioShares Biotechnology Products Fund ETF A Buy?

BioShares Biotechnology Products Fund holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this ETF since the last evaluation from a Strong Buy to a Hold candidate.

Current score: 0.000 Hold/Accumulate Downgraded

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Fair Opening Price

Predicted fair opening price on June 24, 2026 - $92.60 ( 0.0486%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk